Artificial Intelligence Characterizes Cancer At the AACR Annual Meeting 2018, researchers at Google compared the speed and accuracy of human pathologists and computer algorithms in diagnosing and grading cancer. by Kevin McLaughlin A New Type of Drug Approval At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors’ molecular characteristics, not to their tissues of origin. by Kate Yandell Non–Small Cell Lung Cancer Takes Center Stage A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non–small cell lung cancer treatment. by Brad Jones Pembrolizumab Shows Further Promise for Melanoma In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected. by Brad Jones A Better Way to Screen for Lynch Syndrome? Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns. by Cheryl Platzman Weinstock From the Editor-in-Chief DNA Profiling Moves From Forensics to Diagnostics DNA profiling technologies are providing new ways to detect and monitor cancer. by William G. Nelson, MD, PhD Forward Look Banking on Bacteria Response to immunotherapy may be linked to gut microbiome. by Chris Palmer Forward Look Improving Cancer Care in Sub-Saharan Africa New guidelines account for limited medical resources. by Cameron Walker Forward Look Treating Early-Stage Lung Cancer Efforts are underway to define role of high-dose radiation. by Stephen Ornes Searching Blood for Cancer Clues Researchers are developing blood tests that help track and identify molecular changes in tumors. But many hurdles remain before these “liquid biopsies” become standard. by Stephen Ornes next Cancer Talk The Ins and Outs of Tumor Testing In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates. by Kate Yandell The Many Faces of Patient Advocacy Advocates shared their stories and projects at the AACR Annual Meeting. by Kate Yandell Focusing on the Fundamentals National Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency. by Marci A. Landsmann A Response to Roadblocks The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting. by Kevin McLaughlin More Posts